KIG
ABMD

Kowal Investment Group’s Abiomed Inc ABMD Stock Holding History

Kowal Investment Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-120
Closed -$39K – 1015
2021
Q3 		$39K Buy
+120
New +$40.7K 0.01% 275

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Kowal Investment Group's ABMD Position: Q4 2021 in Review

Kowal Investment Group sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 120 shares — an estimated $39K sold.

Kowal Investment Group first reported a position in ABMD in Q3 2021 and held it in 1 quarter. The position peaked at $39K in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Kowal Investment Group reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Kowal Investment Group sold 120 Abiomed Inc shares in Q4 2021, an estimated $39K.
  • Kowal Investment Group first reported a position in Abiomed Inc in Q3 2021 and held it in 1 quarter.
  • Kowal Investment Group's Abiomed Inc position peaked at $39K in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.